Stocktoria
LIXTE BIOTECHNOLOGY HOLDINGS, INC. LIXT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2007-09-21
LIXTE BIOTECHNOLOGY HOLDINGS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Porter Stuart D | director | 2026-05-29 | Grant | 25,000 | — |
| Pursglove Geordan Garrett | CEO and Chairman of the Board | 2026-04-15 | Grant | 350,000 | — |
| Stazzone Peter | Chief Financial Officer | 2026-04-15 | Grant | 50,000 | — |
| Sawyer Jason David | director | 2026-04-15 | Grant | 25,000 | — |
| Felix Lourdes | director | 2026-04-15 | Grant | 25,000 | — |
| Primus Guy Warren | director | 2026-04-15 | Grant | 25,000 | — |
| Holloway Michael Andrew | director | 2026-04-15 | Grant | 25,000 | — |
Source: SEC EDGAR filings · CIK 0001335105 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.